Current Market Information

Last Trade Price (LTP) 210.20 Last Trade Date 08 June, 2023 Change 0.00 % Open Price 210.20 Day's Range 210.20 - 210.20     Total Trade 2 Total Volume 51 Close Price 210.20 Yesterday Close Price 210.20 Market Capital in BDT (mn) 186332.002

Contact Information

Designation Name Mobile Number Email Chairman Mr. Samuel S Chowdhury 01711537666 samuel@squaregroup.com MD Mr. Tapan Chowdhury 01711529977 tapan@squaregroup.com CEO Mr. Tapan Chowdhury 01711529977 tapan@squaregroup.com CFO Mr. Muhammad Zahangir Alam '01714091895 zahangir@squaregroup.com Company Secretary Khandaker Habibuzzaman '01713328886 khandaker@squaregroup.com Office Address Square Centre, 48, Mohakhali C/A, Dhaka - 1212 Phone : 02-8833047-56, 9859007 Fax : 02 -9848768,9853896 Email : cs@squaregroup.com,info@squaregroup.com Website : http://www.squarepharma.com.bd Factory Address Pabna Unit Square Road, Salgaria,Pabna

Basic Information

Authorized Capital in BDT* (mn) 10,000.00 Paid-up Capital in BDT* (mn) 8,864.51 Face Value 10 Paid up Share 886451010     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 1995 Debut Trade Date 21 October, 1995 Type of Instrument     52 Week's Range 207.70 - 218.00 Year End 202206 Reserve / Surplus(mn) 92553 Remarks Financial Performance for the year 2010 shows consolidated figures. Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 30-Apr, 2023 34.67 0 15.09 13.21 37.03 As on 31-Mar, 2023 34.67 0 15.01 13.31 37.01 As on 28-Feb, 2023 34.67 0 14.95 13.36 37.02 As on 30-Jun, 2022 (year ended) 34.67 0 14.85 13.91 36.57     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Dec 14, 2022 AAA ST-1 Stable Dec 13, 2023 Credit Rating Information and Services Limited (CRISL)         Half Year End (HY) Information  202212 HY Net Turnover(mn)  32256.71 HY Net Profit after tax(mn)  10626.49 HY EPS  11.99  AGM Information   AGM Date  24 December, 2022 Record Date  28 November, 2022 Dividend(%)  100.00 (Cash) Bonus Issue  5% 2020,7% 2019,7% 2018,7.5% 2017, 10% 2016, 12.50% 2015, 15% 2014, 30% 2013, 40% 2012, 35% 2011, 30% 2010, 25% 2009, 35% 2008, 50% 2007, 20 06, 15% 2005, 20% 2004

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2022	20.51	0	0	0	116.7	0	18176.74	0	100%C	4.61
2021	17.99	0	0	0	102.54	0	15947.45	0	60%C	2.78
2020	15.82	0	0	0	91.57	0	13354.41	0	47%C,5%B	2.72
2019	16.03	0	0	0	86.03	0	12645.72	0	42%C,7%B	1.59
2018	15.72	0	0	0	78.41	0	11593.96	0	36%C,7%B	1.23

Financial Statements
Quarterly Financial Statement	http://www.squarepharma.com.bd/quarterly-reports.php
Price Sensitive Information	https://www.squarepharma.com.bd/price-sensitive-information.php

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To